Adjuvant chemoradiotherapy vs adjuvant chemotherapy in locally advanced Siewert type II/III adenocarcinoma of gastroesophageal junction after D2/R0 resection

Table 3 Distributions of recurrence in Adjuvant chemoradiotherapy group and adjuvant chemotherapy group

Recurrence site	Adjuvant chemoradiotherapy group		Adjuvant chemotherapy group
	No. of patients	% of recurrence patients (n = 18)	No. of patients	% of recurrence patients (n = 61)
Local recurrence, n (%)
Remnant stomach	1	5.6	1	1.6
Anastomosis site	3	16.7	14	23.0
Regional recurrence	5	27.8	24	39.3
Distant metastasis, n (%)
One site
Peritoneum	5	27.8	8	13.1
Pleura	2	11.1	4	6.6
Solid organ	4	22.2	16	26.2
Distant LNs	2	11.1	5	8.2
Bone metastases	2	11.1	3	4.9
≥ 2 sites
Peritoneum + solid organ	2	11.1	3	4.9
Solid organs	1	5.6	2	3.3
Peritoneum + distant LNs	0	0	1	1.6
Solid organs + distant LNs	0	0	1	1.6

LNs: Lymph nodes.